| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The European Society of Cardiology, the American College of Cardiology Foundation, the American Heart Association, and the World Heart Federation 2007. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Universal definition of myocardial infarction
Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction
Task Force Members,
(Denmark)
(USA)
(New Zealand)
(USA)
(USA)
(Italy)
(Germany)
(USA)
(Denmark)
(USA)
(Denmark)
(Sweden)
(Israel)
(Finland)
(UK)
(The Netherlands)
(USA)
(USA)
(The Netherlands)
(France)
(Belgium)
(USA)
(France)
(USA)
(USA)
(Canada)
(USA)
(UK)
(Germany)
(USA)
(The Netherlands)
(UK)
(Argentina)
(Spain)
(India)
(Switzerland)
(China)
(Sweden)
(Spain)
(UK)
(Ukraine)
(Italy)
(Poland)
(Finland)
ESC Committee for Practice Guidelines,
(France)
(UK)
(Italy)
(France)
(Norway)
(Greece)
(France)
(The Netherlands)
(Denmark)
(France)
(Germany)
(Germany)
(Poland)
(Czech Republic)
(Spain)
Document Reviewers,
(Portugal)
(USA)
(USA)
(USA)
(Germany)
(Singapore)
(Mexico)
(USA)
(USA)
(USA)
(USA)
(Italy)
(Poland)
(France)
* Corresponding authors/co-chairpersons. Professor Kristian Thygesen, Department of Medicine and Cardiology, Aarhus University Hospital, Tage Hansens, Gade 2, DK-8000 Aarhus C, Denmark. Tel: +45 89 49 76 14; fax: +45 89 49 76 19. E-mail: Kristian.Thygesen@as.aaa.dk. Professor Joseph Alpert, Department of Medicine, University of Arizona College of Medicine, 1501 N. Campbell Ave, PO Box 245017, Tucson, AZ 85724-5017, USA. Tel: +1 520 626 6138; fax: +1 520 626 6604. E-mail: jalpert@email.arizona.edu. Professor Harvey White, Green Lane Cardiovascular Service, Auckland City Hospital, Private Bag 92024, 1030 Auckland, New Zealand. Tel: +64 96309992; fax: +64 96309915. E-mail: harveyw@adhb.govt.nz
The recommendations set forth in this report are those of the Task Force Members and do not necessarily reflect the official position of the American College of Cardiology.
Dr Shanti Mendis of the WHO participated in the task force in her personal capacity, but this does not represent WHO approval of this document at the present time. ![]()
This article has been copublished in the October II (Vol. 28 no. 20), 2007, issue of the European Heart Journal (also available on the Web site of the European Society of Cardiology at www.escardio.org), the November 27, 2007, issue of Circulation (also available on the Web site of the American Heart Association at my.americanheart.org), and the November 27, 2007, issue of the Journal of the American College of Cardiology (also available on the Web site of the American College of Cardiology at www.acc.org).
This document was approved by the European Society
| Introduction |
|---|
Clinical features of ischaemia
Pathology
Clinical classification of myocardial infarction
| Biomarker evaluation |
|---|
Reinfarction
| Electrocardiographic detection of myocardial infarction |
|---|
ECG abnormalities of myocardial ischaemia that may evolve to myocardial infarction
Prior myocardial infarction
Conditions that confound the ECG diagnosis of myocardial infarction
Reinfarction
Coronary revascularization
| Imaging techniques |
|---|
Echocardiography
Radionuclide imaging
Magnetic resonance imaging
X-Ray computed tomography
Application in the acute phase of myocardial infarction
Application in the healing or healed phase of myocardial infarction
| Myocardial infarction associated with revascularization procedures |
|---|
Diagnostic criteria for myocardial infarction with PCI
Diagnostic criteria for myocardial infarction with CABG
| Definition of myocardial infarction in clinical investigations |
|---|
| Public policy implications of redefinition of myocardial infarction |
|---|
| Global perspectives of the redefinition of myocardial infarction |
|---|
| Conflicts of interest |
|---|
| Acknowledgements |
|---|
| Footnotes |
|---|
| References |
|---|
Related articles in EHJ:
- Universal definition of myocardial infarction: Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction
- Task Force Members, Kristian Thygesen, Joseph S. Alpert, Harvey D. White, Biomarker Group, Allan S. Jaffe, Fred S. Apple, Marcello Galvani, Hugo A. Katus, L. Kristin Newby, Jan Ravkilde, ECG Group, Bernard Chaitman, Peter M. Clemmensen, Mikael Dellborg, Hanoch Hod, Pekka Porela, Imaging Group, Richard Underwood, Jeroen J. Bax, George A. Beller, Robert Bonow, Ernst E. Van Der Wall, Intervention Group, Jean-Pierre Bassand, William Wijns, T. Bruce Ferguson, Philippe G. Steg, Barry F. Uretsky, David O. Williams, Clinical Investigation Group, Paul W. Armstrong, Elliott M. Antman, Keith A. Fox, Christian W. Hamm, E. Magnus Ohman, Maarten L. Simoons, Global Perspective Group, Philip A. Poole-Wilson, Enrique P. Gurfinkel, José-Luis Lopez-Sendon, Prem Pais, Shanti Mendis, Jun-Ren Zhu, Implementation Group, Lars C. Wallentin, Francisco Fernández-Avilés, Kim M. Fox, Alexander N. Parkhomenko, Silvia G. Priori, Michal Tendera, Liisa-Maria Voipio-Pulkki, ESC Committee for Practice Guidelines, Alec Vahanian, A. John Camm, Raffaele De Caterina, Veronica Dean, Kenneth Dickstein, Gerasimos Filippatos, Christian Funck-Brentano, Irene Hellemans, Steen Dalby Kristensen, Keith McGregor, Udo Sechtem, Sigmund Silber, Michal Tendera, Petr Widimsky, José Luis Zamorano, Document Reviewers, Joao Morais, Sorin Brener, Robert Harrington, David Morrow, Udo Sechtem, Michael Lim, Marco A. Martinez-Rios, Steve Steinhubl, Glen N. Levine, W. Brian Gibler, David Goff, Marco Tubaro, Darek Dudek, and Nawwar Al-Attar
EHJ 2007 28: 2525-2538.[Extract] [Full Text]
This article has been cited by other articles:
![]() |
K. P. Goran Suggestion to list acute aortic dissection as a possible cause of type 2 myocardial infarction (according to the universal definition) Eur. Heart J., October 3, 2008; (2008) ehn429v1. [Full Text] [PDF] |
||||
![]() |
D. N. Tziakas, G. K. Chalikias, I. K. Tentes, D. Stakos, S. V. Chatzikyriakou, K. Mitrousi, A. X. Kortsaris, J. C. Kaski, and H. Boudoulas Interleukin-8 is increased in the membrane of circulating erythrocytes in patients with acute coronary syndrome Eur. Heart J., September 2, 2008; (2008) ehn382v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. McCann, B. M. Glover, I. B.A. Menown, M. J. Moore, J. McEneny, C. G. Owens, B. Smith, P. C. Sharpe, I. S. Young, and J. A. Adgey Novel biomarkers in early diagnosis of acute myocardial infarction compared with cardiac troponin T Eur. Heart J., August 5, 2008; (2008) ehn363v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. Empana, F. Canoui-Poitrine, G. Luc, I. Juhan-Vague, P. Morange, D. Arveiler, J. Ferrieres, P. Amouyel, A. Bingham, M. Montaye, et al. Contribution of novel biomarkers to incident stable angina and acute coronary syndrome: the PRIME Study Eur. Heart J., August 2, 2008; 29(16): 1966 - 1974. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Antman and D. A. Morrow Biomarker Release After Percutaneous Coronary Intervention: A Message From the Heart Circ Cardiovasc Intervent, August 1, 2008; 1(1): 3 - 6. [Full Text] [PDF] |
||||
![]() |
P. W Armstrong Defining myocardial infarction: a work in progress Heart, August 1, 2008; 94(8): 1076 - 1079. [Full Text] [PDF] |
||||
![]() |
N. Johnston, H. Dargie, and A. Jardine Diagnosis and treatment of coronary artery disease in patients with chronic kidney disease Heart, August 1, 2008; 94(8): 1080 - 1088. [Full Text] [PDF] |
||||
![]() |
A. Gray, S. Goodacre, D. E. Newby, M. Masson, F. Sampson, J. Nicholl, and the 3CPO Trialists Noninvasive Ventilation in Acute Cardiogenic Pulmonary Edema N. Engl. J. Med., July 10, 2008; 359(2): 142 - 151. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Schiele, N. Meneveau, and J.-P. Bassand Routine pre-treatment with clopidogrel before diagnostic coronary angiography: the question is right, but what about the answer? Eur. Heart J., June 2, 2008; 29(12): 1475 - 1477. [Full Text] [PDF] |
||||
![]() |
G. A. Lanza The universal definition of myocardial infarction: some issues and concerns Eur. Heart J., May 1, 2008; 29(9): 1209 - 1209. [Full Text] [PDF] |
||||
![]() |
K. Thygesen, J. S. Alpert, A. S. Jaffe, H. D. White, and On behalf of the Joint ESC/ACCF/AHA/WHF Task Force The universal definition of myocardial infarction: some issues and concerns: reply Eur. Heart J., May 1, 2008; 29(9): 1209 - 1210. [Full Text] [PDF] |
||||
![]() |
MEND-CABG II Investigators* Efficacy and Safety of Pyridoxal 5'-Phosphate (MC-1) in High-Risk Patients Undergoing Coronary Artery Bypass Graft Surgery: The MEND-CABG II Randomized Clinical Trial JAMA, April 16, 2008; 299(15): 1777 - 1787. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. S. Apple, S. W. Smith, L. A. Pearce, R. Ler, and M. M. Murakami Use of the Centaur TnI-Ultra Assay for Detection of Myocardial Infarction and Adverse Events in Patients Presenting With Symptoms Suggestive of Acute Coronary Syndrome Clin. Chem., April 1, 2008; 54(4): 723 - 728. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. H.J. Pijls, P. van Schaardenburg, G. Manoharan, E. Boersma, J.-W. Bech, M. van't Veer, F. Bar, J. Hoorntje, J. Koolen, W. Wijns, et al. Reply. J. Am. Coll. Cardiol., March 18, 2008; 51(11): 1123 - 1124. [Full Text] [PDF] |
||||
![]() |
E. Siniorakis, G. Kirvassilis, and N. Exadactylos Intraoperative myocardial infarction in non-cardiac surgery: is a universal definition feasible? Eur. Heart J., February 2, 2008; 29(4): 567 - 567. [Full Text] [PDF] |
||||
![]() |
K. Thygesen, J. S. Alpert, A. S. Jaffe, H. D. White, and On behalf of the Joint ESC/ACCF/AHA/WHF Task Force Intraoperative myocardial infarction in non-cardiac surgery: is a universal definition feasible? reply Eur. Heart J., February 2, 2008; 29(4): 567 - 568. [Full Text] [PDF] |
||||
![]() |
P. Collinson, K. Pulkki, J. Suvisaari, J. Ravkilde, A. Stavljenic-Rukavina, A. Hammerer-Lercher, H. Baum, M. P. van Dieijen-Visser, and P. H. Laitinen How Well Do Laboratories Follow Guidelines on Cardiac Markers? The Cardiac Marker Guideline Uptake in Europe Study Clin. Chem., February 1, 2008; 54(2): 448 - 449. [Full Text] [PDF] |
||||






